KotsevaKWoodDDe BacquerDet al.EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol2016; 23: 636–648.
2.
KotsevaKWoodDDe BackerG. on behalf of EUROASPIRE Investigators. Determinants of participation and risk factor control in coronary patients attending cardiac rehabilitation programmes: results from the EUROASPIRE IV survey. Eur J Prev Cardiol2018; 25: 1242–1251.
3.
PiepoliMFHoesAWAgewallSet al.2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur J Prev Cardiol2016; 23: NP1–NP96.
4.
Van den Brekel-DijkstraKRengersAHNiessenMAet al.Personalized prevention approach with use of a web-based cardiovascular risk assessment with tailored lifestyle follow-up in primary care practice – a pilot study. Eur J Prev Cardiol2016; 23: 544–551.
5.
AvanziniFMarzonaIBavieraMet al.Improving cardiovascular prevention in general practice: results of a comprehensive personalized strategy in subjects at high risk. Eur J Prev Cardiol2016; 23: 947–955.
6.
LaoutarisID. The ‘aerobic/resistance/inspiratory muscle training hypothesis in heart failure’. Eur J Prev Cardiol2018; 25: 1257–1262.
7.
PriceKJGordonBABirdSRet al.A review of guidelines for cardiac rehabilitation exercise programmes: is there an international consensus?Eur J Prev Cardiol2016; 23: 1715–1733.
8.
SarinkDNedkoffcLBriffacTet al.Trends in age and sex-specific prevalence and incidence of cardiovascular disease in Western Australia. Eur J Prev Cardiol2018; 25: 1280–1290.
9.
PiironenMUkkolaOHuikuriHet al.Trends in longterm prognosis after acute coronary syndrome. Eur J Prev Cardiol2017; 24: 274–280.
10.
ZhongYRosengrenAFuMet al.Secular changes in cardiovascular risk factors in Swedish 50-year-old men over a 50-year period: the study of men born in 1913, 1923, 1933, 1943, 1953 and 1963. Eur J Prev Cardiol2017; 24: 612–620.
11.
ZhuK-FWangY-MZhuJ-Zet al.National prevalence of coronary heart disease and its relationship with human development index: a systematic review. Eur J Prev Cardiol2016; 23: 530–543.
CompostellaLCompostellaCTruongLVet al.History of erectile dysfunction as a predictor of poor physical performance after an acute myocardial infarction. Eur J Prev Cardiol2017; 24: 460–467.
14.
FerrarioMMLandsbergisPTsutsumiAet al.for the ICOH Scientific Committee on Cardiology in Occupational Health. Work environment: an opportunity for ground-breaking collaborations in cardiovascular disease prevention. Eur J Prev Cardiol2017; 24(Suppl 2): 4–6.
15.
SkielboeAKMarottJLDixenUet al.Occupational physical activity, but not leisure-time physical activity increases the risk of atrial fibrillation: the Copenhagen City Heart Study. Eur J Prev Cardiol2016; 23: 1883–1893.
16.
TsujimotoTKajioH. Efficacy of renin–angiotensin system inhibitors for patients with heart failure with preserved ejection fraction and mild to moderate chronic kidney disease. Eur J Prev Cardiol2018; 25: 1268–1277.
17.
GuJFanYQBianLet al.Long-term prescription of beta-blocker delays the progression of heart failure with preserved ejection fraction in patients with hypertension: a retrospective observational cohort study. Eur J Prev Cardiol2016; 23: 1421–1428.
18.
O’NealWTSandesaraPBSamman-TahhanAet al.Heart rate and the risk of adverse outcomes in patients with heart failure with preserved ejection fraction. Eur J Prev Cardiol2017; 24: 1212–1219.
